Market Samachar

FDA pauses Regenxbio gene therapy trial again due to safety concerns - STAT

Read full article on STAT ↗

Market Samachar is a news aggregator. This article was originally published by STAT. Tap the button above to read the full story on their site.

• INDIAN Bitcoin tops $80,000 as optimistic mood returns to crypto market Share Market Today
• INDIAN Nifty Midcap index hits new high as earnings, domestic demand drive gains Share Market Today
• INDIAN The House of Abhinandan Lodha enters into MoU with NITCO Share Market Today
• INDIAN United Breweries expands Heineken Silver Across Kerala, Odisha and Madhya Pradesh Share Market Today
• INDIAN First monthly expiry under CAS sees a minor fall in derivatives turnover Share Market Today
• INDIAN HEG demerger becomes effective from 07 Sep 2026 Share Market Today
• INDIAN Noumed Pharmaceuticals renews its supply agreement with leading Australian pharmacy chain Share Market Today
• INDIAN Crude oil prices slide 4% as markets look past Iran sanctions Markets-Economic Times

More from Market Samachar

• Is 'out of control' US tipping culture spreading overseas? BBC News
• Traders are skeptical of Iran timeline for Strait of Hormuz reopening Finance
• Stocks making the biggest moves after hours: Snowflake, Marvell Technology, Agilent Technologies & more Finance
• Boeing CEO says company met requirements to increase 737 Max production to 47 jets per month Business News
• Abercrombie shares jump 12% on earnings beat even as Iran conflict hits sales Business News